Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes. - Wikidata - wikimedia - TriplyDB

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

http://www.wikidata.org/entity/Q46654997

about

Potential Bioactive Compounds from Seaweed for Diabetes Management Resolving futile glucose cycling and glycogenolytic contributions to plasma glucose levels following a glucose load.Quantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolism Lactate and risk of incident diabetes in a case-cohort of the atherosclerosis risk in communities (ARIC) study.Postprandial whole-body glycolysis is similar in insulin-resistant and insulin-sensitive non-diabetic humans Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes.Impact of oxidative stress and peroxisome proliferator-activated receptor gamma coactivator-1alpha in hepatic insulin resistance.Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content.Metabolic inflexibility of white and brown adipose tissues in abnormal fatty acid partitioning of type 2 diabetes.Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance Acarbose: oral anti-diabetes drug with additional cardiovascular benefits.Glucagon-mediated impairments in hepatic and peripheral tissue nutrient disposal are not aggravated by increased lipid availability.Role of postprandial hyperglycemia in cardiovascular disease.Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies.Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.Lactate, a Neglected Factor for Diabetes and Cancer Interaction.Potential role of skeletal muscle glucose metabolism on the regulation of insulin secretion.Oral Insulin Delivery in a Physiologic Context: Review.Regulation of hepatic glucose metabolism in health and disease.Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice.The emerging role of oestrogen-related receptor γ as a regulator of energy metabolism.A Single Day of Excessive Dietary Fat Intake Reduces Whole-Body Insulin Sensitivity: The Metabolic Consequence of Binge Eating.Influence of gastric emptying on the control of postprandial glycemia: physiology and therapeutic implications.Kinetic modeling of human hepatic glucose metabolism in type 2 diabetes mellitus predicts higher risk of hypoglycemic events in rigorous insulin therapy.A break in the brake mechanism in diabetes: a cause of postprandial hyperglycemia.Absorption patterns of meals containing complex carbohydrates in type 1 diabetes.Metabolic fate of plasma glucose during hyperglycemia in impaired glucose tolerance: evidence for further early defects in the pathogenesis of type 2 diabetes.Treatment with the glucagon receptor antagonist LY2409021 increases ambulatory blood pressure in patients with type 2 diabetes.Importance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans.Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes.Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist.

P2860

Q26797339-D4A7E1F0-A531-4ADC-9990-2D1E14AB5F41 Q30635204-830254C1-E93E-4548-B672-81BD3476AE9F Q34325481-997476C3-C1E8-4DEB-AEF6-64092E833712 Q34576075-23C02CC9-1E5B-4F47-BB42-8664D475F55F Q35180118-72F891CA-DC8B-42C1-A10C-878D6580FC9F Q35762651-28BD6C62-83D7-438D-B296-7F25197D81ED Q36182540-D5CDF1C5-C012-437C-9F94-A6A62403FB7C Q36807584-649CDFC8-8CF7-4A01-83A0-121ED30E1E5B Q36842541-DB4F7FCC-A569-4568-9CF5-318922F1ADAD Q36850836-6DEB7BD3-DE49-470D-9B0D-51887F643A56 Q36975704-408A5126-BADD-45E2-B83A-92EDA1AF0CE4 Q37014973-AA5ABC71-2772-4F31-90BA-FAA831FA0905 Q37076275-6A58FD11-2E40-4816-9C0D-E86C2C98137B Q37190101-3597DA0E-E17C-4E18-8603-654AC507C275 Q37197094-966189E0-CBA8-4801-BBFA-84EA0F6C5E45 Q37446672-473E1AE5-DCCD-4F68-99A5-C3C27FAA3847 Q37524302-BA07E2A2-D104-4C3A-BF32-5EDF6602E179 Q37547661-A0702029-3CA4-4549-8AFD-B704D3214AD5 Q38195143-C1D7C8B2-C0C8-4CFB-B1D3-9889818B1B8C Q39400642-72DFBDBB-E427-4A77-BD91-CAF7A56EA9AC Q39450184-CBB8FAF1-31E9-48C8-A77E-D0160D5A62FC Q40147836-B86BBED2-2F29-437B-ADF8-46A0B1F98B19 Q41328950-7B09A9AA-5C75-4B93-B651-C00DC6838863 Q41499323-68355F20-903C-48C1-860F-05147BE4FA26 Q41583875-9D6EDC75-79F6-4A89-92C2-279C885D0387 Q41845491-D116B381-DB55-46F5-9074-774142EE3644 Q41847888-1F85E274-B238-4E06-9B68-83957E71CD5E Q43242144-1DD01EA1-6E8E-4519-B2D2-76D44BEE31C2 Q44774309-C2A2E15F-087E-4811-8C2B-17D7D8D767BB Q46164580-42D0E19B-5E4B-4D98-AD60-D73D7CB56393 Q46378864-DA781ACD-30DD-4D01-B9FF-7EE3DEAA4B98 Q46923072-FE7EAABC-A5A5-4175-BE21-AD5221BBF281 Q47443616-0E5FD062-6368-40D5-BE65-973DEDCF7354 Q51286181-21F214AD-744D-4B88-B208-0F27FC65D310 Q55032630-BDB265EF-C79A-409D-B7CB-73287A1EC656

P2860

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

http://www.wikidata.org/entity/Q46654997

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

@en

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

@nl

type

label

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

@en

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

@nl

prefLabel

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

@en

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

@nl

P1433

Q46654997-E39CB869-54B3-470F-8D61-10D4A94648C5

P1476

Q46654997-3ECA0165-AC35-442B-BB42-0D1E28F0786B

P2093

Q46654997-163C4CB7-62FC-47A0-AB4B-6C52B33C041A

Q46654997-645A4AC5-52BA-4260-A5A3-8EE681C22719

Q46654997-9487649C-5473-47A7-9E7A-008600B3F5A5

Q46654997-A1167A75-F61E-491C-8F79-BF5D4154B44C

Q46654997-A40534FB-31D3-4A9F-AC1D-E85AE018E68F

Q46654997-B923AF2A-F81D-4BD1-92C0-30E1D03461CF

Q46654997-D2D18FCA-7B99-4719-8238-6883CF5D4454

Q46654997-D97DA904-16C0-4A7E-9E96-8241AEBBA190

P2860

Q46654997-038DDEE4-2206-4442-8835-A0BE60209100

Q46654997-0397E619-4215-457C-85BF-992A430FD37C

Q46654997-0439DE62-BCAD-4A0C-88D0-088890FE46E2

Q46654997-090C3B09-4307-4366-AA4E-C0CCB35A3293

Q46654997-0DEF1799-D324-468E-98F6-F673D88539AC

Q46654997-11CF8758-4C38-4005-9A9A-86116123031F

Q46654997-1491158C-ABC4-4760-A58D-8DAC77B8AA6C

Q46654997-157C3F7A-3E31-452C-AEFD-D8BA3FAF9F5F

Q46654997-1E90B37F-F716-4D52-B7E3-8564DB892E24

Q46654997-2410C2D0-7E01-458A-B2A2-2A88B97803F9

P304

Q46654997-1893C4B6-9675-4956-B2C1-3327AE9B4FC0

P31

Q46654997-5AEA1BD3-3C29-4130-9F1C-452B878A8EC1

P356

Q46654997-C7C695E1-88E1-40D9-9074-35D5951D97C1

P433

Q46654997-6333C2D5-CB45-4DB7-91FB-E211B3503B62

P478

Q46654997-BD461426-74DA-4831-A663-B8595669A6FB

P577

Q46654997-4A7CCD51-FCBF-43ED-B244-AE24D97ED26C

P5875

Q46654997-BA2F1904-001F-4E4D-835A-1E9030B4CCF5

P698

Q46654997-081FDD75-D3FA-43E2-8795-5CB810307045

P921

Q46654997-07FC3387-6934-4C00-994D-E6668772DE90

P356

AJPENDO.00529.2004

P1433

American Journal of Physiology - Endocrinology and Metabolism

P1476

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

@en

P2093

Christian Meyer

http://www.w3.org/2001/XMLSchema#string

Ervin Szoke

http://www.w3.org/2001/XMLSchema#string

Hans J Woerle

http://www.w3.org/2001/XMLSchema#string

Jean M Dostou

http://www.w3.org/2001/XMLSchema#string

John E Gerich

http://www.w3.org/2001/XMLSchema#string

Niyaz R Gosmanov

http://www.w3.org/2001/XMLSchema#string

Stephen L Welle

http://www.w3.org/2001/XMLSchema#string

Steven D Wittlin

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Use of 14CO2 in estimating rates of hepatic gluconeogenesis

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus

The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus.

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.

P304

E67-E77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPENDO.00529.2004

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

290

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7654558

http://www.w3.org/2001/XMLSchema#string

P698

16105859

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes